CLINICAL STUDIES
Early impairment of coronary flow reserve in young men with borderline hypertension
Hanna Laine, MDa,
Olli T. Raitakari, MDa,
Harri Niinikoski, MDa,
Olli-Pekka Pitkänen, MDa,
Hidehiro Iida, DSca*,
Jorma Viikari, MDa,
Pirjo Nuutila, MDa and
Juhani Knuuti, MDa
a Departments of Medicine, Clinical Physiology, Cardiorespiratory Research Unit and Nuclear Medicine, Turku Positron Emission Tomography Centre, Turku University, Turku, Finland
* Research Institute for Brain and Blood Vessels, Akita, Japan
Manuscript received October 6, 1997;
revised manuscript received March 25, 1998,
accepted April 9, 1998.
Address for correspondence: Dr. Hanna Laine, Department of Medicine, University of Turku, FIN-20520 Turku, Finland hannal{at}pet.tyks.fi
Objectives. The purpose of this study was to investigate whether functional abnormalities in coronary vasomotion are present in young healthy asymptomatic men fulfilling the World Health Organization (WHO) criteria for borderline hypertension.
Background. Previous studies have reported reduced coronary flow reserve in middle-aged subjects with sustained hypertension and hypertension-induced microvascular heart disease or left ventricular hypertrophy.
Methods. Myocardial blood flow was measured at baseline and during dipyridamole-induced hyperemia by means of positron emission tomography and oxygen-15labeled water in asymptomatic young men with borderline hypertension (group 1: n = 16, mean ± SD age 37 ± 4 years, 24-h ambulatory blood pressure 135 ± 10/81 ± 9 mm Hg) and matched healthy control subjects (group 2: n = 19, age 35 ± 3 years, 24-h ambulatory blood pressure 119 ± 8/69 ± 8 mm Hg, p < 0.001). Left ventricular (LV) mass, dimensions and function were measured by echocardiography.
Results. LV mass, dimensions and diastolic function were similar in the study groups. Baseline myocardial blood flow was similar (0.83 ± 0.21 vs. 0.80 ± 0.22 ml/g per min, group 1 vs. group 2, respectively, p = NS), and a significant increase in flow was detected after dipyridamole infusion (0.56 mg/kg body weight in 4 min intravenously) in both groups. However, the flow response to dipyridamole was significantly lower in group 1, leading to lower hyperemic flow in group 1 than in group 2 (2.85 ± 1.20 vs. 3.80 ± 1.44 ml/g per min, respectively). Consequently, the coronary flow response was lower in hypertensive than in normotensive men (3.46 ± 1.23 vs. 4.99 ± 2.5 ml/g per min, group 1 vs. group 2, respectively, p < 0.05).
Conclusions. These results demonstrate reduced coronary reactivity present in young asymptomatic men with borderline hypertension and no signs of hypertension-induced angina or left ventricular hypertrophy. Because baseline basal myocardial blood flow was unchanged, the reduction in coronary flow reserve depends on an impaired maximal vasodilator capacity.
|
Abbreviations and Acronyms
| | ECG | = electrocardiogram, electrocardiographic | | [15O]CO | = oxygen-15labeled carbon monoxide | | HDL | = high density lipoprotein | | [15O]H2O | = oxygen-15labeled water | | LDL | = low density lipoprotein | | LV | = left ventricular | | LVM | = left ventricular mass | | PET | = positron emission tomography (tomographic) | | ROI | = region of interest | | WHO | = World Health Organization |
|
This article has been cited by other articles:

|
 |

|
 |
 
N. Koivuviita, R. Tertti, M. Jarvisalo, M. Pietila, J. Hannukainen, J. Sundell, P. Nuutila, J. Knuuti, and K. Metsarinne
Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
Nephrol. Dial. Transplant.,
September 1, 2009;
24(9):
2773 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Raher, H. Thibault, K. K. Poh, R. Liu, E. F. Halpern, G. Derumeaux, F. Ichinose, W. M. Zapol, K. D. Bloch, M. H. Picard, et al.
In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3 Deficient Mice
Circulation,
September 11, 2007;
116(11):
1250 - 1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Vigano, M. Turiel, V. Martina, E. Meregalli, L. Tomasoni, G. De Blasio, L. Delfino, A. Edefonti, P. Grillo, M. Procaccio, et al.
Reduced coronary flow reserve in young adults with renal transplant
Nephrol. Dial. Transplant.,
August 1, 2007;
22(8):
2328 - 2333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Eur. Heart J.,
April 1, 2007;
28(7):
788 - 797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Erdogan, I. Yildirim, O. Ciftci, I. Ozer, M. Caliskan, H. Gullu, and H. Muderrisoglu
Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function
Circulation,
February 6, 2007;
115(5):
593 - 599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. O. Kiviniemi, A. Snapir, M. Saraste, J. O. Toikka, O. T. Raitakari, M. Ahotupa, J. J. Hartiala, M. Scheinin, and J. W. Koskenvuo
Determinants of coronary flow velocity reserve in healthy young men
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H564 - H569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Indermuhle, R. Vogel, P. Meier, S. Wirth, R. Stoop, M. G. Mohaupt, and C. Seiler
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans
Eur. Heart J.,
July 1, 2006;
27(13):
1571 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rodriguez-Porcel, X.-Y. Zhu, A. R. Chade, B. Amores-Arriaga, N. M. Caplice, E. L. Ritman, A. Lerman, and L. O. Lerman
Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H978 - H984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pellegrino, G. Storto, P. P. Filardi, A. R. Sorrentino, A. Silvestro, M. Petretta, G. Brevetti, M. Chiariello, M. Salvatore, and A. Cuocolo
Relationship Between Brachial Artery Flow-Mediated Dilation and Coronary Flow Reserve in Patients with Peripheral Artery Disease
J. Nucl. Med.,
December 1, 2005;
46(12):
1997 - 2002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Brunken, J. K. Perloff, J. Czernin, R. Campisi, S. Purcell, P. D. Miner, J. S. Child, and H. R. Schelbert
Myocardial perfusion reserve in adults with cyanotic congenital heart disease
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1798 - H1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. E. Vicario, L. Cirillo, G. Storto, T. Pellegrino, N. Ragone, L. Fontanella, M. Petretta, D. Bonaduce, and A. Cuocolo
Influence of Risk Factors on Coronary Flow Reserve in Patients with 1-Vessel Coronary Artery Disease
J. Nucl. Med.,
September 1, 2005;
46(9):
1438 - 1443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Buus, M. Bottcher, C. G. Jorgensen, K. L. Christensen, K. Thygesen, T. T. Nielsen, and M. J. Mulvany
Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or {beta}-Blockade in Patients With Essential Hypertension
Hypertension,
October 1, 2004;
44(4):
465 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sundell, E. Engblom, J. Koistinen, A. Ylitalo, A. Naum, K. Q. Stolen, R. Kalliokoski, S. G. Nekolla, K. E. J. Airaksinen, J. J. Bax, et al.
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure
J. Am. Coll. Cardiol.,
March 17, 2004;
43(6):
1027 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Laine, J Sundell, P Nuutila, O T Raitakari, M Luotolahti, T Ronnemaa, T Elomaa, P Koskinen, and J Knuuti
Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes
Heart,
March 1, 2004;
90(3):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi
The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT
J. Nucl. Med.,
May 1, 2003;
44(5):
745 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Langerak, H. W. Vliegen, J. W. Jukema, P. Kunz, A. H. Zwinderman, H. J. Lamb, E. E. van der Wall, and A. de Roos
Value of Magnetic Resonance Imaging for the Noninvasive Detection of Stenosis in Coronary Artery Bypass Grafts and Recipient Coronary Arteries
Circulation,
March 25, 2003;
107(11):
1502 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Paiva, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, and O. T. Raitakari
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia
J. Am. Coll. Cardiol.,
October 2, 2002;
40(7):
1241 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aronson, D. Boisvert, and W. Lapp
Isolated Systolic Hypertension Is Associated with Adverse Outcomes from Coronary Artery Bypass Grafting Surgery
Anesth. Analg.,
May 1, 2002;
94(5):
1079 - 1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sundell, P. Nuutila, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and J. Knuuti
Dose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow
Diabetes,
April 1, 2002;
51(4):
1125 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scognamiglio, A. Avogaro, S. Vigili de Kreutzenberg, C. Negut, M. Palisi, E. Bagolin, and A. Tiengo
Effects of Treatment With Sulfonylurea Drugs or Insulin on Ischemia-Induced Myocardial Dysfunction in Type 2 Diabetes
Diabetes,
March 1, 2002;
51(3):
808 - 812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany
Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia
Circulation,
November 6, 2001;
104(19):
2305 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Koskenvuo, J. J. Hartiala, J. Knuuti, H. Sakuma, J. O. Toikka, M. Komu, M. Saraste, and P. Niemi
Assessing Coronary Sinus Blood Flow in Patients with Coronary Artery Disease: A Comparison of Phase-Contrast MR Imaging with Positron Emission Tomography
Am. J. Roentgenol.,
November 1, 2001;
177(5):
1161 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Schwartz and M. G. Bourassa
Evaluation of Patients With Chest Pain and Normal Coronary Angiograms
Arch Intern Med,
August 13, 2001;
161(15):
1825 - 1833.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Fujiwara, T Tamura, K Yoshida, K Nakagawa, M Nakao, M Yamanouchi, N Shikama, T Himi, and Y Masuda
Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors
Eur. Heart J.,
March 2, 2001;
22(6):
479 - 487.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi
Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
130 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Laine, P. Nuutila, M. Luotolahti, C. Meyer, T. Elomaa, P. Koskinen, T. Rönnemaa, and J. Knuuti
Insulin-Induced Increment of Coronary Flow Reserve Is Not Abolished by Dexamethasone in Healthy Young Men
J. Clin. Endocrinol. Metab.,
May 1, 2000;
85(5):
1868 - 1873.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al.
Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy
Circulation,
December 14, 1999;
100(24):
2425 - 2430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Ward and N. A. Herity
Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients
Circulation,
October 26, 1999;
100
(17):
84e - e85.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Yokoyama, S.-i. Momomura, T. Ohtake, K. Yonekura, W. Yang, N. Kobayakawa, T. Aoyagi, S. Sugiura, N. Yamada, K. Ohtomo, et al.
Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy
Circulation,
July 13, 1999;
100(2):
117 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|